REFERENCES

1. Banuchi V, Mallen J, Kraus D. Cancers of the nose, sinus, and skull base. Surg Oncol Clin N Am. 2015;24:563-77.

2. Loevner LA, Sonners AI. Imaging of neoplasms of the paranasal sinuses. Magn Reson Imaging Clin N Am. 2002;10:467-93.

3. Daniels DL, Mafee MF, Smith MM, et al. The frontal sinus drainage pathway and related structures. Am J Neuroradiol. 2003;24:1618-27.

4. Laine FJ, Smoker WR. The ostiomeatal unit and endoscopic surgery: anatomy, variations, and imaging findings in inflammatory diseases. Am J Roentgenol. 1992;159:849-57.

5. Landsberg R, Friedman M. A computer-assisted anatomical study of the nasofrontal region. Laryngoscope. 2001;111:2125-30.

6. DeMonte F, Ginsberg LE, Clayman GL. Primary malignant tumors of the sphenoidal sinus. Neurosurgery. 2000;46:1084-91; discussion 1091.

7. Netter FH. Netter atlas of human anatomy: classic regional approach. 8th edition. Elsevier. 2022. Available from: https://books.google.com/books?id=-ydgEAAAQBAJ&printsec=frontcover&hl=zh-CN&source=gbs_ge_summary_r&cad=0#v=onepage&q&f=false. [Last accessed on 25 Aug 2025].

8. Harnsberger HR, Osborn AG, MacDonald A, et al. Diagnostic and surgical imaging anatomy: brain, head & neck, spine. Am J Neuroradiol. 2007;28:795-6.

9. Famuyide A, Juliano A, Moonis G. MRI of Sinonasal Malignancies. Top Magn Reson Imaging. 2021;30:139-49.

10. Loevner LA, Sonners AI. Imaging of neoplasms of the paranasal sinuses. Neuroimaging Clin N Am. 2004;14:625-46.

11. Madani G, Beale TJ, Lund VJ. Imaging of sinonasal tumors. Semin Ultrasound CT MR. 2009;30:25-38.

12. Madani G, Beale TJ. Differential diagnosis in sinonasal disease. Semin Ultrasound CT MR. 2009;30:39-45.

13. Eggesbø HB. Imaging of sinonasal tumours. Cancer Imaging. 20127;12:136-52.

14. Eisen MD, Yousem DM, Montone KT, et al. Use of preoperative MR to predict dural, perineural, and venous sinus invasion of skull base tumors. Am J Neuroradiol. 1996;17:1937-45.

15. McIntyre JB, Perez C, Penta M, Tong L, Truelson J, Batra PS. Patterns of dural involvement in sinonasal tumors: prospective correlation of magnetic resonance imaging and histopathologic findings. Int Forum Allergy Rhinol. 2012;2:336-41.

16. Maroldi R, Lombardi D, Farina D, Nicolai P, Moraschi I, Pianta L. Malignant neoplasms. In: Maroldi R, Nicolai P, editors. Imaging in treatment planning for sinonasal diseases. New York, Springer-Verlag; 2005. pp. 159-220.

17. Maroldi R, Farina D, Battaglia G, Maculotti P, Nicolai P, Chiesa A. MR of malignant nasosinusal neoplasms. Frequently asked questions. Eur J Radiol. 1997;24:181-90.

18. Eisen MD, Yousem DM, Loevner LA, Thaler ER, Bilker WB, Goldberg AN. Preoperative imaging to predict orbital invasion by tumor. Head Neck. 2000;22:456-62.

19. Agarwal M, Policeni B. Sinonasal Neoplasms. Semin Roentgenol. 2019;54:244-57.

20. Kuan EC, Wang EW, Adappa ND, et al. International Consensus Statement on Allergy and Rhinology: sinonasal tumors. Int Forum Allergy Rhinol. 2024;14:149-608.

21. Hawley KA, Ahmed M, Sindwani R. CT findings of sinonasal respiratory epithelial adenomatoid hamartoma: a closer look at the olfactory clefts. Am J Neuroradiol. 2013;34:1086-90.

22. Tong KN, Serra RM, Shih RY, Foss RD. Seromucinous hamartoma of the nasal cavity. Head Neck Pathol. 2019;13:239-42.

23. Chawla A, Shenoy J, Chokkappan K, Chung R. Imaging features of sinonasal inverted papilloma: a pictorial review. Curr Probl Diagn Radiol. 2016;45:347-53.

24. Jeon TY, Kim HJ, Chung SK, et al. Sinonasal inverted papilloma: value of convoluted cerebriform pattern on MR imaging. Am J Neuroradiol. 2008;29:1556-60.

25. Agarwal A, Bhatt AA, Bathla G, et al. Update from the 5th Edition of the WHO Classification of Nasal, Paranasal, and Skull Base Tumors: imaging overview with histopathologic and genetic correlation. Am J Neuroradiol. 2023;44:1116-25.

26. Mishra S, Praveena NM, Panigrahi RG, Gupta YM. Imaging in the diagnosis of juvenile nasopharyngeal angiofibroma. J Clin Imaging Sci. 2013;3:1.

27. Valkadinov I, Conev N, Dzhenkov D, Donev I. Rare case of ameloblastoma with pulmonary metastases. Intractable Rare Dis Res. 2017;6:211-4.

28. Thawani R, Kim MS, Arastu A, et al. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. 2023;73:72-112.

29. Hermans R, De Vuysere S, Marchal G. Squamous cell carcinoma of the sinonasal cavities. Semin Ultrasound CT MR. 1999;20:150-61.

30. Homma A, Hayashi R, Matsuura K, et al. Lymph node metastasis in t4 maxillary sinus squamous cell carcinoma: incidence and treatment outcome. Ann Surg Oncol. 2014;21:1706-10.

31. Dean KE, Shatzkes D, Phillips CD. Imaging review of new and emerging sinonasal tumors and tumor-like entities from the Fourth Edition of the World Health Organization Classification of Head and Neck Tumors. AJNR Am J Neuroradiol. 2019;40:584-90.

32. Leivo I. Sinonasal adenocarcinoma: update on classification, immunophenotype and molecular features. Head Neck Pathol. 2016;10:68-74.

33. Abouhanine O, Merzem A, Ndayishimiye V, et al. Sinonasal chondrosarcoma, an unusual location. Eur J Case Rep Intern Med. 2020;7:001933.

34. Dublin AB, Bobinski M. Imaging characteristics of olfactory neuroblastoma (esthesioneuroblastoma). J Neurol Surg B Skull Base. 2016;77:1-5.

35. Schuster JJ, Phillips CD, Levine PA. MR of esthesioneuroblastoma (olfactory neuroblastoma) and appearance after craniofacial resection. Am J Neuroradiol. 1994;15:1169-77.

36. Som PM, Lidov M, Brandwein M, Catalano P, Biller HF. Sinonasal esthesioneuroblastoma with intracranial extension: marginal tumor cysts as a diagnostic MR finding. Am J Neuroradiol. 1994;15:1259-62.

37. Navas-Campo R, Moreno Caballero L, Gasos Lafuente A, Tobajas Morlana P, Séez Valero E, Gimeno Peribáñez MJ. Olfactory neuroblastoma. Everything the radiologist should know. Rev Argent Radiol. 2020;84:17-29. Available from: https://www.rardigital.org.ar/_files/ugd/b2c01b_e67b8ca53e7942f0aa6cdb4888d6c2af.pdf. [Last accessed on 25 Aug 2025]

38. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery. 1993;32:706-14; discussion 714.

39. Xu CC, Dziegielewski PT, McGaw WT, Seikaly H. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. J Otolaryngol Head Neck Surg. 2013;42:2.

40. Phillips CD, Futterer SF, Lipper MH, Levine PA. Sinonasal undifferentiated carcinoma: CT and MR imaging of an uncommon neoplasm of the nasal cavity. Radiology. 1997;202:477-80.

41. Virarkar M, Saleh M, Ramani NS, Morani AC, Bhosale P. Imaging spectrum of NUT carcinomas. Clin Imaging. 2020;67:198-206.

42. Shatzkes DR, Ginsberg LE, Wong M, et al. Imaging appearance of SMARCB1 (INI1)-deficient sinonasal carcinoma: a newly described sinonasal malignancy. Am J Neuroradiol. 2016;37:1925-9.

43. Lin N, Qi M, Wang Z, et al. Small cell neuroendocrine carcinoma of paranasal sinuses: radiologic features in 14 cases. J Comput Assist Tomogr. 2021;45:135-41.

44. Zhu Q Zhu W Wu J, Zhang H. The CT and MRI observations of small cell neuroendocrine carcinoma in paranasal sinuses. World J Surg Oncol. 2015;13:54.

45. Andrianakis A, Kiss P, Pomberger M, Wolf A, Thurnher D, Tomazic PV. Sinonasal mucosal melanoma: treatment strategies and survival rates for a rare disease entity: a single center experience and review of literature. Wien Klin Wochenschr. 2021;133:1137-47.

46. Amit M, Na’ara S, Hanna EY. Contemporary treatment approaches to sinonasal mucosal melanoma. Curr Oncol Rep 2018;20:10.

47. Kim YK, Choi JW, Kim HJ, et al. Melanoma of the sinonasal tract: value of a septate pattern on precontrast T1-weighted MR imaging. Am J Neuroradiol. 2018;39:762-67.

48. Famuyide A, Juliano A, Moonis G. MRI of sinonasal malignancies. Top Magn Reson Imaging. 2021;30:139-49.

49. Pfister DG, Spencer S, Adkins D, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Head and neck cancers. 2023. Available from: https://nio.gov.pl/wp-content/uploads/2024/01/Wytyczne-postepowania-diagnostyczno-terapeutycznego-u-chorych-na-nowotwory-glowy-i-szyi-adaptacja-NCCN.pdf. [Last accessed on 25 Aug 2025].

50. Schwartz JS, Brooks SG, Stubbs V, et al. Temporal patterns of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography sinonasal uptake after treatment of sinonasal malignancy. Int Forum Allergy Rhinol. 2016;6:1301-7.

51. Ho AS, Tsao GJ, Chen FW, et al. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013;119:1349-56.

52. Khalili S, Worrall DM, Brooks S, et al. Endoscopy versus imaging: analysis of surveillance methods in sinonasal malignancy. Head Neck. 2016;38:1229-33.

53. Dunsky KA, Wehrmann DJ, Osman MM, Thornberry BM, Varvares MA. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient. Laryngoscope. 2013;123:2161-4.

54. Chao SS, Loh KS, Tan LK. Modalities of surveillance in treated nasopharyngeal cancer. Otolaryngol Head Neck Surg. 2003;129:61-4.

55. Harvey RJ, Pitzer G, Nissman DB, et al. PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010;32:76-84.

56. Kaplan DJ, Kim JH, Wang E, Snyderman C. Prognostic indicators for salvage surgery of recurrent sinonasal malignancy. Otolaryngol Head Neck Surg. 2016;154:104-12.

57. Tzelnick S, Levin EG, Yacobi D, Mizrachi A, Popovtzer A, Soudry E. Recurrence patterns and efficacy of surveillance modalities for sinonasal malignancies. Am J Rhinol Allergy. 2022;36:473-9.

58. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91:1063-72.

59. Kim SA, Chung YS, Lee BJ. Recurrence patterns of sinonasal cancers after a 5-year disease-free period. Laryngoscope. 2019;129:2451-7.

60. Han AY, Nader ME, Lam K, Su SY. Current status of sinonasal cancer survivorship care. Head Neck. 2023;45:2458-68.

61. Deppen SA, Blume J, Bobbey AJ, et al. 68Ga-DOTATATE Compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis. J Nucl Med. 2016;57:872-8.

62. Dadgar H, Norouzbeigi N, Ahmadzadehfar H, Assadi M. 68Ga-DOTATATE and 18F-FDG PET/CT for the management of esthesioneuroblastoma of the sphenoclival region. Clin Nucl Med. 2020;45:e363-4.

63. Liu KY, Goldrich DY, Ninan SJ, et al. The value of ⁶⁸Gallium-DOTATATE PET/CT in sinonasal neuroendocrine tumor management: a case series. Head Neck. 2021;43:E30-40.